- Home
- TFC vs BDX Comparison
TFC vs BDX Comparison
Compare TFC & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TFC | BDX |
|---|---|---|
| Founded | 1872 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8B | 54.6B |
| IPO Year | 2007 | 1998 |
Fundamental Metrics
Financial Performance| Metric | TFC | BDX |
|---|---|---|
| Price | $48.94 | $195.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 22 | 16 |
| Target Price | $53.19 | ★ $195.57 |
| AVG Volume (30 Days) | ★ 7.4M | 1.4M |
| Earning Date | 10-16-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.29% | 2.11% |
| EPS Growth | ★ 13.69 | N/A |
| EPS | ★ 2.31 | 1.59 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.41 | $2.34 |
| P/E Ratio | ★ $21.00 | $125.17 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $43.13 | $140.11 |
| 52 Week High | $56.20 | $213.08 |
Technical Indicators
Market Signals| Indicator | TFC | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 60.18 | 62.19 |
| Support Level | $48.07 | $195.63 |
| Resistance Level | $49.11 | $213.08 |
| Average True Range (ATR) | 0.84 | 3.95 |
| MACD | 0.45 | 1.14 |
| Stochastic Oscillator | 93.88 | 78.74 |
Price Performance
Historical ComparisonAbout TFC Truist Financial Corporation
Truist Financial is one of the three super-regional banks in the US, with around $550 billion in assets as of the end of the second quarter of 2026. Truist emerged from the 2019 merger of BB&T and SunTrust. Based in Charlotte, North Carolina, the bank has a footprint largely in the mid-Atlantic and Southeast. Apart from retail and commercial banking operations, the bank also offers online and point-of-sale consumer lending, cards, wealth management, investment banking, and other banking services.
About BDX Becton Dickinson and Company
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.